Hide

FocusBar

Subscribe to Premium Member
Switch to:
Insider Position Date Buy/Sell Shares Shares Owned Following This Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
TERRY JAMES W JRDirector2013-02-21Buy1,50010,922$14212.86Link
TERRY JAMES W JRDirector2013-02-06Buy1,2009,422$13.7916.54.42Link
Wright Murray HDirector2012-11-01Sell3,007204,322$13.941.83.6Link
Wright Murray HDirector2012-10-26Sell1,800207,329$13.9253.6Link
BRAM CRAIG CCEO & President
(Click for the stocks that their CEOs have bought)
2012-09-07Buy5,00058,162$12.964.511.63Link
Wright Murray HDirector2012-09-07Sell5,000209,129$12.964.511.63Link
TERRY JAMES W JRDirector2012-08-27Buy2,0008,222$13.022610.6Link
BRAM CRAIG CCEO & President2012-08-27Buy5,00053,162$136510.77Link
TERRY JAMES W JRDirector2012-08-24Buy2,0006,222$132610.77Link
BRAM CRAIG CCEO & President2011-11-23Buy1,00048,162$9.799.847.09Link
BRAM CRAIG CCEO & President2011-11-23Buy1,00047,162$9.99.945.45Link
BRAM CRAIG CCEO & President2011-11-15Buy1,00046,162$10.5510.636.49Link
BRAM CRAIG CCEO & President2011-11-11Buy50045,162$10.555.336.49Link
BRAM CRAIG CCEO & President2011-11-08Buy1,16044,662$10.712.434.58Link
Wright Murray HDirector2011-11-04Buy20,000212,531$9.93198.645.02Link
TERRY JAMES W JRDirector2011-08-17Buy1,0002,624$10.510.537.14Link
BRAM CRAIG CCEO & President2011-08-10Buy36343,502$10.023.643.71Link
BRAM CRAIG CCEO and President2011-07-25Buy2,00041,638$12.124.219.01Link
BRAAM RONALD HRetired CEO & former Director2011-05-31Sell4,34073,350$14.5763.2-1.17Link
BRAAM RONALD HRetired CEO & former Director2011-05-24Sell71068,890$14.510.3-0.69Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.


GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK